Intranasal delivery of RIG-I agonist drives pulmonary myeloid cell activation in mice
Viral respiratory infections cause substantial health and economic burden. There is a pressing demand for efficacious vaccination strategies and, therefore, a need for a better understanding of the mechanisms of action of novel potential adjuvants. Here we investigated the effect of a synthetic RIG-...
Saved in:
Main Authors: | Nair, Sajith, Wu, Yilun, Nguyen, Trinh Mai, Fink, Katja, Luo, Dahai, Ruedl, Christiane |
---|---|
Other Authors: | Lee Kong Chian School of Medicine (LKCMedicine) |
Format: | Article |
Language: | English |
Published: |
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/161476 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
THERMAL STABILITY STUDY OF AQUEOUS OXTOCIN FORMULATION FOR INTRANASAL DELIVERY
by: LIM MING WEI
Published: (2015) -
CHITOSAN AND ITS DERIVATIVE NANOPARTICLES FOR DRUG DELIVERY INTO BRAIN USING INTRANASAL ADMINISTRATION: PREPARATION, CHARACTERIZATION, IN VITRO AND IN VIVO EVALUATION
by: LIU SHANSHAN
Published: (2016) -
The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon-β response
by: Kim, Susana Soo-Yeon, et al.
Published: (2019) -
Intranasal delivery of self-assembly insulin nanocomplexes based on surface modified trimethyl chitosan
by: Anchalee Jintanapattanakit
Published: (2023) -
Ablating the aryl hydrocarbon receptor (AhR) in CD11c+ cells perturbs intestinal epithelium development and intestinal immunity
by: Chng, Song Hui, et al.
Published: (2016)